FIRST WAVE BIOPHARMA (FWBI)
US33749P4081 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 3.71M | 1.36M | 8.25M | 6.06M | 180.00K | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 0.00 | 90.00K | 0.00 | 550.00K | 2.64M | |||
| Other Current Assets | 1.24M | 1.96M | 1.18M | 1.26M | 600.00K | |||
| Total Current Assets | 4.96M | 3.41M | 9.42M | 7.87M | 3.41M | |||
| Non-Current Assets | ||||||||
| PPE Net | 210.01K | 300.00K | 410.00K | 90.00K | 160.00K | |||
| Goodwill | 1.68M | 1.68M | 1.91M | 2.05M | 1.89M | |||
| Intangibles | N/A | N/A | 0.00 | 2.88M | 3.41M | |||
| Other Non-Current Assets | 32.77K | 40.00K | 40.00K | 30.00K | 40.00K | |||
| Total Non-Current Assets | 1.93M | 2.03M | 2.37M | 5.05M | 5.49M | |||
| TOTAL ASSETS | 6.88M | 5.44M | 11.79M | 12.92M | 8.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 612.78K | 600.00K | 640.00K | 550.00K | 1.52M | |||
| Accrued Expenses | 892.40K | 390.00K | 500.00K | 180.00K | 150.00K | |||
| Accounts Payable | 554.28K | 720.00K | 2.68M | 1.56M | 2.21M | |||
| Other Current Liabilities | 1.07M | 770.00K | 8.48M | 13.25M | 390.00K | |||
| Total Current Liabilities | 3.13M | 2.48M | 12.30M | 15.55M | 4.29M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 146.95K | 210.00K | 7.31M | 20.00K | 0.00 | |||
| Total Non-Current Liabilities | 146.95K | 220.00K | 7.31M | 10.00K | 0.00 | |||
| TOTAL LIABILITIES | 3.28M | 2.70M | 19.61M | 15.56M | 4.29M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -184.33M | -168.53M | -153.90M | -95.37M | -62.69M | |||
| Additional Paid In Capital | 187.93M | 171.28M | 147.31M | 93.83M | 68.58M | |||
| Common Shares | 160.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | 0.00 | -1.22M | -1.11M | -1.27M | |||
| Shares Outstanding | 1.56M | 1.00M | 70.00K | 10.00K | 10.00K | |||
| Tangible Book Value per Share | 1.23 | 1.06 | -139.00 | -757.00 | -68.00 | |||
| Total Shareholders' Equity | 3.60M | 2.74M | -7.82M | -2.64M | 4.62M | |||
| TOTAL LIABILITIES AND EQUITY | 6.88M | 5.44M | 11.79M | 12.92M | 8.90M | |||
| Statistics | ||||||||
| Current Ratio | 1.58 | 1.38 | 0.77 | 0.51 | 0.79 | |||
| Return On Assets (ROA) | -233.95% | -275.18% | -716.88% | -322.99% | -170.56% | |||
| Return On Equity (ROE) | -446.94% | -546.35% | N/A | N/A | -328.57% | |||
All data in USD